Clearpoint Neuro

Yahoo Finance • 18 days ago

ClearPoint forecasts $52m-$56m 2026 revenue range as IRRAflow could be cash neutral as early as 2027

Earnings Call Insights: ClearPoint Neuro (CLPT) Q1 2026 MANAGEMENT VIEW * “Our company has started 2026 on a strong note by achieving record revenue of $12.1 million for the quarter,” and this was “driven primarily by organic devices g... Full story

Yahoo Finance • 24 days ago

HubSpot downgraded, Qualcomm upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Daiwa upgraded Qualcomm (QCOM) to Outp... Full story

Yahoo Finance • 2 months ago

After-Hours Earnings Report for March 17, 2026 : LULU, DOCU, OKLO, HQY, NN, QFIN, TRVI, CLPT, CBUS, OPTT, STRR, SDST

The following companies are expected to report earnings after hours on 03/17/2026. Visit our Earnings Calendar for a full list of expected earnings releases. lululemon athletica inc. (LULU)is reporting for the quarter ending January 31... Full story

Yahoo Finance • 6 months ago

Here’s What Boosted ClearPoint Neuro (CLPT) in Q3

Deep Sail Capital, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. The fund returned 5.8% net of fees in the third quarter, outperforming the Russell 2000 Mid Cap G... Full story

Yahoo Finance • 8 months ago

ClearPoint Neuro Surges Nearly 40% - Can The Stock Retest Its 52-week High?

(RTTNews) - Shares of ClearPoint Neuro Inc. (CLPT) are up nearly 40% at $17 in premarket trading on Wednesday. This global device, cell, and gene therapy-enabling company operates in two segments: (i) a business providing medical devices... Full story

Yahoo Finance • 10 months ago

ClearPoint Neuro outlines global expansion plans and anticipates regulatory milestones while advancing cell and gene therapy initiatives

Earnings Call Insights: ClearPoint Neuro (CLPT) Q2 2025 MANAGEMENT VIEW * Joseph Michael Burnett, CEO, described 2025 as the start of ClearPoint Neuro’s “third phase,” called Fast. Forward., emphasizing an expanded commitment to cell a... Full story

Yahoo Finance • 10 months ago

ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Mixed Q2 2025 Results with Record Revenue but Narrow EPS Miss

CLEARPOINT NEURO REPORTS MIXED Q2 2025 RESULTS AMID STRATEGIC EXPANSION CLEARPOINT NEURO INC (NASDAQ:CLPT [https://www.chartmill.com/stock/quote/CLPT]) announced its second-quarter 2025 financial results, delivering record revenue but fal... Full story

Yahoo Finance • 10 months ago

Here are the major earnings after the close Tuesday

Major earnings expected after the bell on Tuesday include: * CoreWeave (CRWV [https://seekingalpha.com/symbol/CRWV]) * Inovio Pharmaceuticals (INO [https://seekingalpha.com/symbol/INO]) * Luminar Technologies (LAZR [https://seekinga... Full story

Yahoo Finance • 11 months ago

ClearPoint Neuro May 2025 presentation: Enters 'Fast Forward' phase after Q1 revenue beat

Introduction & Market Context ClearPoint Neuro Inc. (NASDAQ:CLPT) unveiled its corporate presentation on May 13, 2025, highlighting the company’s strategic vision as it enters what management calls the "Fast Forward" phase of its developm... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023

SOLANA BEACH, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will releas... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles

SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it will present inve... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will relea... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model

SOLANA BEACH, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive world... Full story

Yahoo Finance • 3 years ago

A ClearPoint Neuro Anuncia Aprovação da Carteira de Navegação Neuro pela ANVISA no Brasil

SOLANA BEACH, Califórnia, April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (a "Empresa"), uma empresa de plataforma global que fornece navegação e entrega ao cérebro, anunciou hoje o registo bem sucedido da sua ca... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced successful registr... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS

SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced further expansion... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro annonce un accord de licence exclusif pluriannuel avec l'UCSF concernant une plateforme innovante pour l'administration cellulaire intracérébrale

SOLANA BEACH, Californie, 28 mars 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT) (la « Société »), une société mondiale de plateformes thérapeutiques permettant la navigation et l'administration vers le cerveau, annonce... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro gibt exklusive mehrjährige Lizenzvereinbarung mit UCSF für innovative intrazerebrale Zellverabreichungsplattform bekannt

SOLANA BEACH, Kalifornien, March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (das „Unternehmen“), ein weltweites Unternehmen für therapieermöglichende Plattformen, das die Navigation zum und die Verabreichung im Ge... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform

SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive multi... Full story